SARAH MUELLER: Open Payments
NPI 1851025696 · FREDERICKTOWN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 75 payments from 12 companies in 2025. Trend: 2023 $123 · 2024 $649 · 2025 $1,332
Food & beverage: $1,324Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $315 |
| ABBVIE INC. | 14 | $227 |
| Otsuka America Pharmaceutical, Inc. | 10 | $156 |
| Vanda Pharmaceuticals Inc. | 6 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $97 |
| Alkermes, Inc. | 5 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $63 |
| Lundbeck LLC | 2 | $44 |
Products named: CAPLYTA, VRAYLAR, FANAPT, INGREZZA, ARISTADA, ABILIFY MAINTENA, COBENFY, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
